Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
Xingyue He(Changchun University of Chinese Medicine), Sai Murali Krishna Pulukuri(Takeda (United States)), Neil Bence(Takeda (United States)), Ryan Chau(Takeda (United States)), Lawrence R. Dick(Millennium Engineering and Integration (United States)), Mike Sintchak(Takeda (United States)), Hugues Bernard(Takeda (United States)), James Minissale(Takeda (United States)), Erik Koenig(Millennium Engineering and Integration (United States)), James E. Brownell(AstraZeneca (United States)), Claudia Rabino(Takeda (United States)), He N. Xu(Takeda (United States)), Jianping Guo(Sun Yat-sen University), Teresa A. Soucy(Millennium Engineering and Integration (United States)), Melissa Gallery(Takeda (United States)), Zhigen Hu(Takeda (United States)), Hua Liao(Millennium Engineering and Integration (United States)), Steven Langston(Millennium Engineering and Integration (United States)), Hirotake Mizutani(Millennium Engineering and Integration (United States)), Jessica Riceberg(Takeda (United States)), Dylan B. England(Takeda (United States)), Kristina Xega(Takeda (United States)), Xiaofeng Yang(Millennium Engineering and Integration (United States)), Zhonghua Yan(Takeda (United States)), Pooja Shah(Takeda (United States)), John Bradley(Gladstone Institutes), Eric S. Lightcap(Minneapolis Business College), John Newcomb(Takeda (United States)), Matt O. Duffey(Takeda (United States))
Cited by 228
Related Papers
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
|Nature Reviews Drug Discovery|2010|554